Efficacy and Safety of Incobotulinumtoxina in the Combined Treatment of Upper Facial Lines

Trial Profile

Efficacy and Safety of Incobotulinumtoxina in the Combined Treatment of Upper Facial Lines

Completed
Phase of Trial: Phase III

Latest Information Update: 25 May 2015

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Facial-wrinkles; Glabellar lines; Skin aging
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 May 2015 Primary efficacy endpoints met; All response rate significant with Botulinum toxin when compared with placebo.
    • 25 May 2015 New trial record
    • 24 Mar 2015 Results presented at the 73rd Annual Meeting of the American Academy of Dermatology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top